logo

For the Inventor, By the Inventor

Belgrade, Republic of Serbia

Radomir B Crkvenjakov

This inventor holds 9 USPTO granted patents. Top assignees: Hyseq, Inc., Callida Genomics, Inc., Hyseg, Inc.. Active years: 1993-2002.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Radomir B Crkvenjakov. Retrieved from https://idiyas.com/inventor/radomir-b-crkvenjakov

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 9

% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 8

Forward Citations = 1,867(Granted Patents)


Location History:

  • Belgrade, YU (1996)
  • Sunnyvale, CA (US) (2001)
  • Beograd, YU (1993 - 2002)

Company Filing History:

goldMedal6 out of 37 
 
Hyseq, Inc.
 patents
silverMedal1 out of 25 
 
Callida Genomics, Inc.
 patents
bronzeMedal1 out of 1 
 
Hyseg, Inc.
 patent
4. 1 out of 834,513 
Other
 patents

Years Active: 1993-2002

Loading Chart...
9 patents (USPTO):Explore Patents
1. 6451996 - Method of sequencing of genomes by hybridization of oligonucleotide probes (2002-09-17),
2. 6316191 - Computer-aided analysis system for sequencing by hybridization (2001-11-13),
3. 6018041 - Method of sequencing genomes by hybridization of oligonucleotide probes (2000-01-25),
4. 5972619 - Computer-aided analysis system for sequencing by hybridization (1999-10-26),
5. 5695940 - Method of sequencing by hybridization of oligonucleotide probes (1997-12-09),
6. 5667972 - Method of sequencing of genoms by hybridization of oligonucleotide probes (1997-09-16),
7. 5525464 - Method of sequencing by hybridization of oligonucleotide probes (1996-06-11),
8. 5492806 - Method of determining an ordered sequence of subfragments of a nucleic (1996-02-20),
9. 5202231 - Method of sequencing of genomes by hybridization of oligonucleotide (1993-04-13),

Title: Radomir B Crkvenjakov: Innovator in Genome Sequencing

Introduction

Radomir B Crkvenjakov, based in Beograd, YU, is a prominent inventor recognized for his significant contributions to genomics and DNA sequencing technologies. With a total of nine patents under his belt, Crkvenjakov has played an instrumental role in shaping methodologies that enhance our understanding of complex genomes.

Latest Patents

Crkvenjakov's latest patents reveal groundbreaking methods in genome sequencing through the hybridization of oligonucleotide probes. One notable invention outlines how DNA sequences can be determined by ensuring oligonucleotides hybridize exclusively with homologous sequences. His patent details an innovative process where DNA molecules are simultaneously hybridized in a systematic manner, employing about 50,000 to 100,000 groups of probes. This process allows for the robust sequencing of mammalian genomes in a streamlined, factory-like environment.

Another of his significant patents involves a computer-aided analysis system that utilizes overlapping oligonucleotide probes to determine nucleic acid sequence information efficiently. This method extends the utility of short oligomers, enabling sequencing to be achieved in a single process for complex genomic materials.

Career Highlights

Throughout his career, Crkvenjakov has engaged with renowned companies such as Hyseq, Inc., where he has contributed to pioneering genome sequencing technologies. His research and inventions are highly regarded in the field, making substantial impacts on genetic research and diagnostics.

Collaborations

Radomir Crkvenjakov has also collaborated with fellow inventor Radoje Drmanac, further enhancing innovations in the field of molecular biology and genomics. This partnership highlights the importance of collaboration in driving scientific advancements and creating effective technologies.

Conclusion

Radomir B Crkvenjakov stands out as a visionary inventor in the realm of genome sequencing, with his patents providing advanced methodologies that are essential for modern genetic research. His work, influenced by collaborations with experts in the field, continues to push the boundaries of what's possible in understanding genetic information and complex genomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…